Total | 1 + PRN Group | 3 + PRN Group | P | |
---|---|---|---|---|
Baseline | ||||
Number (patients/eyes) | 60/60 | 30/30 | 30/30 | NA |
Gender(Male/ Female) | 27/33 | 15/15 | 12/18 | 0.436 |
Age, years | 57.43 ± 13.06 | 57.33 ± 14.47 | 57.53 ± 11.73 | 0.953 |
Diagnosis (non-ischemic/ ischemic) | 36/24 | 16/14 | 20/10 | 0.292 |
BCVA (LogMAR) | 0.758 ± 0.413 | 0.77 ± 0.371 | 0.746 ± 0.466 | 0.823 |
CFT, μm | 520.4 ± 186.5 | 522.4 ± 191.5 | 518.4 ± 184.5 | 0.935 |
Final | ||||
BCVA (LogMAR) | 0.434 ± 0.283 | 0.462 ± 0.261 | 0.405 ± 0.306 | 0.445 |
CFT, μm | 295.1 ± 71.2 | 300.2 ± 89.3 | 290 ± 47.7 | 0.580 |
Number of injections during 12 mo | 4.4 ± 1.5 | 4.0 ± 1.6 | 4.7 ± 1.3 | 0.068 |